MIDAZOLAM HYDROCHLORIDE

MIDAZOLAM HYDROCHLORIDE was reported 27286 times

MIDAZOLAM HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 176 0.5809
1 MITOCHONDRIAL DNA MUTATION 38 0.4419
2 NEW ONSET REFRACTORY STATUS EPILEPTICUS 40 0.3636
3 TRIGEMINO-CARDIAC REFLEX 27 0.3333
4 CHEST WALL RIGIDITY 20 0.3125
5 NEGATIVE PRESSURE PULMONARY OEDEMA 26 0.2653
6 MYOGLOBIN URINE PRESENT 62 0.2520
7 PROPOFOL INFUSION SYNDROME 160 0.2270
8 INTRA-ABDOMINAL PRESSURE INCREASED 35 0.2229
9 CSF OLIGOCLONAL BAND PRESENT 25 0.1923
10 BURKHOLDERIA TEST POSITIVE 23 0.1855
11 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 63 0.1658
12 AIRWAY PEAK PRESSURE INCREASED 25 0.1645
13 ANAL PROLAPSE 19 0.1610
14 NECROSIS ISCHAEMIC 60 0.1302
15 UNWANTED AWARENESS DURING ANAESTHESIA 39 0.1189
16 NEUROMUSCULAR BLOCK PROLONGED 42 0.1138
17 MYOCARDIAL DEPRESSION 29 0.1124
18 FEMALE GENITAL TRACT FISTULA 191 0.1118
19 POSTOPERATIVE DELIRIUM 22 0.1111
20 ANAESTHETIC COMPLICATION NEUROLOGICAL 99 0.1093
21 HEPATIC ISCHAEMIA 32 0.1029
22 MULTIPLE-DRUG RESISTANCE 305 0.0983
23 HYPERTHERMIA MALIGNANT 141 0.0947
24 NEUROMUSCULAR BLOCKADE 21 0.0938
25 AIRWAY COMPLICATION OF ANAESTHESIA 23 0.0875
26 DELAYED RECOVERY FROM ANAESTHESIA 82 0.0865
27 CARCINOID CRISIS 17 0.0752
28 POSTICTAL PARALYSIS 18 0.0744
29 PNEUMATOSIS 33 0.0740
30 PROCTITIS 205 0.0731
31 RADICULOPATHY 184 0.0697
32 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 70 0.0659
33 STATUS EPILEPTICUS 698 0.0617
34 DIABETES INSIPIDUS 147 0.0610
35 RENAL ISCHAEMIA 32 0.0585
36 PSEUDOPOLYP 21 0.0583
37 UPPER AIRWAY OBSTRUCTION 51 0.0575
38 NEONATAL RESPIRATORY DEPRESSION 19 0.0572
39 PO2 INCREASED 28 0.0552
40 BLOOD GASES ABNORMAL 29 0.0538
41 PCO2 INCREASED 38 0.0534
42 TACHYPHYLAXIS 18 0.0516
43 ACIDOSIS HYPERCHLORAEMIC 30 0.0505
44 PLEOCYTOSIS 29 0.0498
45 SEDATION COMPLICATION 126 0.0493
46 VOCAL CORD DYSFUNCTION 24 0.0487
47 PROCEDURAL HYPOTENSION 39 0.0458
48 LABILE BLOOD PRESSURE 54 0.0455
49 PROCEDURAL VOMITING 29 0.0446
50 SEIZURE CLUSTER 36 0.0434
51 CHRONIC SINUSITIS 162 0.0431
52 RESPIRATORY ACIDOSIS 164 0.0417
53 CLONIC CONVULSION 29 0.0396
54 ADENOMA BENIGN 32 0.0372
55 CHANGE IN SEIZURE PRESENTATION 24 0.0371
56 PARADOXICAL DRUG REACTION 132 0.0358
57 MACROGLOSSIA 19 0.0345
58 ABDOMINAL COMPARTMENT SYNDROME 22 0.0345
59 ENDOTRACHEAL INTUBATION COMPLICATION 20 0.0339
60 DERMATOSIS 21 0.0336
61 ELECTROENCEPHALOGRAM ABNORMAL 105 0.0332
62 ENCEPHALITIS AUTOIMMUNE 43 0.0327
63 PULSELESS ELECTRICAL ACTIVITY 134 0.0320
64 APNOEIC ATTACK 18 0.0319
65 ANTICHOLINERGIC SYNDROME 50 0.0314
66 PARTIAL SEIZURES 160 0.0305
67 KOUNIS SYNDROME 69 0.0304
68 TONIC CONVULSION 43 0.0303
69 ANAESTHETIC COMPLICATION 81 0.0301
70 TONIC CLONIC MOVEMENTS 39 0.0300
71 PROCEDURAL NAUSEA 24 0.0298
72 DISSOCIATIVE DISORDER 21 0.0291
73 PERFORATION 23 0.0285
74 HYPERCAPNIA 86 0.0285
75 SYMPTOM MASKED 20 0.0275
76 HYPOVENTILATION 88 0.0270
77 DELAYED GRAFT FUNCTION 19 0.0267
78 SEROTONIN SYNDROME 512 0.0266
79 MATERNAL EXPOSURE DURING DELIVERY 26 0.0262
80 HAEMODYNAMIC INSTABILITY 197 0.0258
81 MYOCLONIC EPILEPSY 39 0.0257
82 RESPIRATORY DEPRESSION 312 0.0254
83 APALLIC SYNDROME 18 0.0248
84 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 93 0.0243
85 INTESTINAL INFARCTION 22 0.0242
86 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 80 0.0241
87 BRADYCARDIA FOETAL 20 0.0241
88 CERUMEN IMPACTION 22 0.0240
89 CARDIOVASCULAR INSUFFICIENCY 39 0.0239
90 VASOPLEGIA SYNDROME 39 0.0238
91 TOXIC ENCEPHALOPATHY 119 0.0235
92 INTESTINAL ISCHAEMIA 129 0.0234
93 BLOOD PH DECREASED 40 0.0234
94 MYOCLONUS 278 0.0233
95 FIBROMA 21 0.0229
96 MUCOSAL ULCERATION 23 0.0228
97 PUPILS UNEQUAL 26 0.0227
98 HYPERAMMONAEMIC ENCEPHALOPATHY 39 0.0224
99 SUBCUTANEOUS EMPHYSEMA 22 0.0224
100 CLONUS 61 0.0223
101 AUTONOMIC NERVOUS SYSTEM IMBALANCE 65 0.0222
102 BRAIN HYPOXIA 22 0.0218
103 GENERALISED TONIC-CLONIC SEIZURE 360 0.0217
104 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 23 0.0209
105 SYSTOLIC DYSFUNCTION 22 0.0209
106 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 22 0.0207
107 BRAIN DEATH 64 0.0207
108 OXYGEN THERAPY 34 0.0207
109 APNOEA 160 0.0205
110 ENDOTRACHEAL INTUBATION 57 0.0203
111 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 44 0.0200
112 REDUCED FACIAL EXPRESSION 20 0.0197
113 LONG QT SYNDROME 47 0.0196
114 AMYLASE INCREASED 72 0.0195
115 SEIZURE LIKE PHENOMENA 33 0.0194
116 NEPHROGENIC DIABETES INSIPIDUS 22 0.0191
117 BLOOD LACTIC ACID INCREASED 100 0.0190
118 OXYGEN SATURATION ABNORMAL 53 0.0187
119 METHAEMOGLOBINAEMIA 43 0.0186
120 BLOOD BICARBONATE DECREASED 35 0.0185
121 STRESS CARDIOMYOPATHY 107 0.0184
122 HEPATORENAL SYNDROME 31 0.0184
123 ISCHAEMIC HEPATITIS 25 0.0182
124 HYPERTHERMIA 137 0.0179
125 HYPORESPONSIVE TO STIMULI 21 0.0179
126 LARYNGOSPASM 48 0.0178
127 GENE MUTATION 35 0.0177
128 WHITE MATTER LESION 22 0.0174
129 HYPERAMMONAEMIA 85 0.0170
130 VAGINAL DISCHARGE 171 0.0169
131 SINUS ARREST 26 0.0166
132 VENTRICULAR HYPOKINESIA 53 0.0165
133 FANCONI SYNDROME 23 0.0163
134 ACIDOSIS 124 0.0162
135 ORAL CANDIDIASIS 213 0.0162
136 BRAIN OEDEMA 203 0.0161
137 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 42 0.0160
138 SUPERINFECTION 24 0.0160
139 BEZOAR 22 0.0159
140 NECROTISING COLITIS 20 0.0158
141 QUADRIPARESIS 26 0.0157
142 VULVOVAGINAL CANDIDIASIS 21 0.0155
143 HYPERTROPHIC CARDIOMYOPATHY 24 0.0155
144 PNEUMOMEDIASTINUM 28 0.0155
145 MULTIPLE ORGAN DYSFUNCTION SYNDROME 434 0.0153
146 COMPLEX PARTIAL SEIZURES 17 0.0153
147 HYPERNATRAEMIA 76 0.0152
148 BRADYPNOEA 41 0.0152
149 HYPOXIA 534 0.0151
150 PUPIL FIXED 26 0.0150
151 MIXED LIVER INJURY 45 0.0149
152 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 75 0.0146
153 STRIDOR 43 0.0146
154 DRUG CLEARANCE DECREASED 19 0.0145
155 CATATONIA 76 0.0145
156 ACUTE LUNG INJURY 17 0.0143
157 NEPHROGENIC ANAEMIA 66 0.0142
158 TROPONIN INCREASED 108 0.0142
159 MYOGLOBIN BLOOD INCREASED 21 0.0137
160 BRAIN HERNIATION 41 0.0137
161 METABOLIC ACIDOSIS 430 0.0134
162 INTRA-ABDOMINAL HAEMORRHAGE 32 0.0134
163 RESPIRATORY RATE DECREASED 42 0.0134
164 ACUTE RESPIRATORY DISTRESS SYNDROME 233 0.0132
165 DEVICE RELATED SEPSIS 26 0.0129
166 LEFT VENTRICULAR HYPERTROPHY 55 0.0128
167 CIRCULATORY COLLAPSE 218 0.0128
168 KLEBSIELLA INFECTION 64 0.0126
169 CELL DEATH 25 0.0126
170 VENTRICULAR ARRHYTHMIA 46 0.0126
171 PSEUDOMONAL SEPSIS 22 0.0125
172 LARGE INTESTINAL STENOSIS 25 0.0125
173 ANAPHYLACTIC SHOCK 320 0.0124
174 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 33 0.0124
175 ANTICONVULSANT DRUG LEVEL INCREASED 20 0.0124
176 DRUG LEVEL BELOW THERAPEUTIC 68 0.0123
177 NEUROLEPTIC MALIGNANT SYNDROME 146 0.0123
178 RENAL NEOPLASM 26 0.0122
179 ABDOMINAL RIGIDITY 33 0.0122
180 QUADRIPLEGIA 25 0.0121
181 MACULAR DEGENERATION 145 0.0121
182 HEPATITIS FULMINANT 36 0.0121
183 EXTREMITY NECROSIS 21 0.0120
184 BEHAVIOUR DISORDER 65 0.0120
185 TROPONIN I INCREASED 20 0.0120
186 AREFLEXIA 32 0.0120
187 UNRESPONSIVE TO STIMULI 309 0.0120
188 TOXIC EPIDERMAL NECROLYSIS 180 0.0118
189 STUPOR 38 0.0118
190 HYPERKINESIA 25 0.0118
191 DYSCHEZIA 36 0.0118
192 ANAPHYLACTIC REACTION 642 0.0116
193 CARDIAC ARREST 950 0.0115
194 APRAXIA 17 0.0115
195 AXILLARY PAIN 17 0.0114
196 DELIRIUM 396 0.0114
197 PATENT DUCTUS ARTERIOSUS 45 0.0113
198 MUSCLE RIGIDITY 135 0.0113
199 BRADYCARDIA 598 0.0113
200 VENTRICULAR FIBRILLATION 125 0.0112
201 CARDIOGENIC SHOCK 161 0.0112
202 BRONCHOSPASM 160 0.0112
203 RHABDOMYOLYSIS 464 0.0111
204 RESPIRATORY ALKALOSIS 18 0.0111
205 DISTRIBUTIVE SHOCK 25 0.0110
206 SINUS BRADYCARDIA 106 0.0110
207 ILLUSION 18 0.0109
208 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 280 0.0109
209 PUPILLARY REFLEX IMPAIRED 20 0.0108
210 OLIGURIA 67 0.0108
211 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 103 0.0108
212 DISSEMINATED INTRAVASCULAR COAGULATION 151 0.0107
213 PULSE ABSENT 51 0.0107
214 TACHYPNOEA 145 0.0107
215 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 585 0.0107
216 SEIZURE 1229 0.0106
217 GAZE PALSY 18 0.0106
218 ENCEPHALOPATHY 259 0.0105
219 PARAESTHESIA ORAL 152 0.0105
220 CATHETER SITE HAEMORRHAGE 26 0.0104
221 HYPERPARATHYROIDISM SECONDARY 26 0.0104
222 NYSTAGMUS 55 0.0104
223 SHOCK 238 0.0103
224 HYPERREFLEXIA 36 0.0103
225 LANGUAGE DISORDER 22 0.0102
226 PNEUMONIA STAPHYLOCOCCAL 20 0.0101
227 MYDRIASIS 130 0.0101
228 VENTRICULAR TACHYCARDIA 166 0.0100
229 LEFT VENTRICULAR DYSFUNCTION 67 0.0100
230 RESPIRATORY FAILURE 720 0.0099
231 VENTRICULAR EXTRASYSTOLES 102 0.0098
232 PETIT MAL EPILEPSY 50 0.0098
233 INCREASED BRONCHIAL SECRETION 25 0.0098
234 HYPOTONIA 97 0.0097
235 TORSADE DE POINTES 76 0.0097
236 NEUROLOGICAL DECOMPENSATION 22 0.0095
237 FAECAL CALPROTECTIN INCREASED 30 0.0095
238 ARTERIOSPASM CORONARY 38 0.0095
239 FREQUENT BOWEL MOVEMENTS 255 0.0094
240 COAGULOPATHY 157 0.0094
241 ANURIA 81 0.0094
242 COLITIS 354 0.0093
243 HYPERLACTACIDAEMIA 25 0.0093
244 ANAPHYLACTOID REACTION 38 0.0092
245 HYPOVOLAEMIA 54 0.0092
246 INTRACRANIAL PRESSURE INCREASED 51 0.0091
247 PNEUMONIA FUNGAL 36 0.0091
248 FOETAL DEATH 47 0.0091
249 HYPERTRANSAMINASAEMIA 63 0.0090
250 CEREBRAL ATROPHY 36 0.0090
251 HEPATIC CYTOLYSIS 115 0.0090
252 RASH MORBILLIFORM 25 0.0090
253 OXYGEN SATURATION DECREASED 503 0.0089
254 ALTERED STATE OF CONSCIOUSNESS 191 0.0088
255 ACUTE RESPIRATORY FAILURE 168 0.0087
256 SHOCK HAEMORRHAGIC 71 0.0087
257 HEPATOCELLULAR INJURY 123 0.0087
258 DEPRESSED LEVEL OF CONSCIOUSNESS 341 0.0086
259 SINUS TACHYCARDIA 121 0.0085
260 LARGE INTESTINAL ULCER 23 0.0085
261 SUPRAVENTRICULAR TACHYCARDIA 81 0.0085
262 IRON DEFICIENCY 38 0.0084
263 PUSTULE 20 0.0084
264 EPILEPSY 257 0.0084
265 SUBDURAL HAEMORRHAGE 23 0.0084
266 LEUKOCYTOSIS 152 0.0084
267 HYPERPHOSPHATAEMIA 18 0.0084
268 RESPIRATORY ARREST 229 0.0083
269 COMA SCALE ABNORMAL 24 0.0083
270 COMA 391 0.0082
271 ELECTROCARDIOGRAM T WAVE INVERSION 18 0.0081
272 HYPOTENSION 1627 0.0081
273 DRUG DIVERSION 50 0.0081
274 SEDATION 212 0.0081
275 VENTRICULAR DYSFUNCTION 21 0.0081
276 PROCEDURAL COMPLICATION 62 0.0081
277 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 49 0.0080
278 HYPERAESTHESIA 66 0.0080
279 PULMONARY ALVEOLAR HAEMORRHAGE 45 0.0080
280 ANTINUCLEAR ANTIBODY POSITIVE 26 0.0080
281 BLOOD CREATINE PHOSPHOKINASE INCREASED 230 0.0080
282 DRUG INTERACTION 1261 0.0079
283 CHOLESTASIS 152 0.0079
284 ACUTE HEPATIC FAILURE 108 0.0079
285 AGITATION 579 0.0079
286 COVID-19 PNEUMONIA 93 0.0079
287 STARING 19 0.0079
288 DRUG LEVEL ABOVE THERAPEUTIC 36 0.0079
289 DERMATITIS EXFOLIATIVE GENERALISED 27 0.0078
290 MIOSIS 62 0.0077
291 THROMBOPHLEBITIS 27 0.0077
292 WRONG PRODUCT ADMINISTERED 52 0.0077
293 MULTI-ORGAN FAILURE 133 0.0077
294 TACHYCARDIA 681 0.0077
295 PARAPLEGIA 22 0.0076
296 ILEUS PARALYTIC 34 0.0076
297 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 25 0.0076
298 ATELECTASIS 72 0.0074
299 CARDIOPULMONARY FAILURE 29 0.0074
300 ISCHAEMIA 34 0.0074
301 SEPTIC SHOCK 321 0.0074
302 NECROTISING FASCIITIS 26 0.0074
303 ATRIOVENTRICULAR BLOCK 57 0.0074
304 HYPERBILIRUBINAEMIA 76 0.0073
305 POLYURIA 60 0.0073
306 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 54 0.0072
307 HYPERTONIA 41 0.0072
308 POTENTIATING DRUG INTERACTION 24 0.0071
309 ELECTROCARDIOGRAM QT PROLONGED 256 0.0071
310 MYOCARDIAL ISCHAEMIA 80 0.0070
311 BUNDLE BRANCH BLOCK RIGHT 32 0.0070
312 ACUTE PULMONARY OEDEMA 39 0.0069
313 ILEUS 86 0.0069
314 HYPOTHERMIA 70 0.0069
315 ORTHOPNOEA 22 0.0069
316 PNEUMONIA ASPIRATION 172 0.0069
317 CYANOSIS 108 0.0069
318 HYPERTRIGLYCERIDAEMIA 40 0.0068
319 THROMBOCYTOSIS 25 0.0068
320 ENCEPHALITIS 47 0.0068
321 EOSINOPHILIA 119 0.0068
322 RASH MACULO-PAPULAR 151 0.0068
323 ATRIOVENTRICULAR BLOCK FIRST DEGREE 29 0.0067
324 APPENDICITIS PERFORATED 17 0.0067
325 RESPIRATORY DISTRESS 184 0.0067
326 FUNCTIONAL GASTROINTESTINAL DISORDER 23 0.0066
327 ELECTROCARDIOGRAM ABNORMAL 52 0.0066
328 PNEUMOTHORAX 105 0.0066
329 CARDIOTOXICITY 59 0.0066
330 CARDIO-RESPIRATORY ARREST 273 0.0065
331 PULMONARY HAEMORRHAGE 51 0.0065
332 BLOOD LACTATE DEHYDROGENASE INCREASED 103 0.0065
333 THROMBOTIC MICROANGIOPATHY 63 0.0065
334 DRUG RESISTANCE 166 0.0065
335 RHINOVIRUS INFECTION 25 0.0064
336 PSEUDOMONAS INFECTION 55 0.0064
337 TRISMUS 33 0.0064
338 HYPOPNOEA 22 0.0063
339 ASPIRATION 69 0.0063
340 ACUTE KIDNEY INJURY 946 0.0062
341 LOW BIRTH WEIGHT BABY 49 0.0062
342 ATAXIA 73 0.0061
343 HEPATIC FAILURE 184 0.0061
344 DRUG LEVEL INCREASED 101 0.0061
345 PREMATURE DELIVERY 96 0.0060
346 COLITIS ULCERATIVE 269 0.0060
347 HEPATITIS ACUTE 39 0.0060
348 METABOLIC ENCEPHALOPATHY 18 0.0060
349 NEUROTOXICITY 105 0.0060
350 BRAIN INJURY 60 0.0060
351 BACTERAEMIA 71 0.0060
352 TYPE I HYPERSENSITIVITY 21 0.0060
353 MALABSORPTION 31 0.0059
354 BLOOD PRESSURE SYSTOLIC DECREASED 27 0.0059
355 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 30 0.0059
356 BLOOD MAGNESIUM DECREASED 51 0.0059
357 BRAIN NATRIURETIC PEPTIDE INCREASED 18 0.0058
358 RECTAL HAEMORRHAGE 250 0.0058
359 LARGE INTESTINE POLYP 40 0.0058
360 DYSTONIA 112 0.0058
361 ANAL ABSCESS 31 0.0057
362 HYPOKALAEMIA 265 0.0057
363 BLOOD POTASSIUM INCREASED 93 0.0057
364 PSYCHOMOTOR HYPERACTIVITY 95 0.0057
365 URINE OUTPUT DECREASED 50 0.0057
366 ACUTE CORONARY SYNDROME 47 0.0057
367 DERMATITIS BULLOUS 41 0.0057
368 TOXICITY TO VARIOUS AGENTS 954 0.0057
369 FIBRIN D DIMER INCREASED 20 0.0056
370 PREMATURE BABY 168 0.0056
371 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 33 0.0056
372 RESPIRATORY RATE INCREASED 49 0.0055
373 ELECTROLYTE IMBALANCE 64 0.0055
374 LACTIC ACIDOSIS 178 0.0055
375 ORGAN FAILURE 22 0.0055
376 CARDIOMEGALY 67 0.0054
377 HYPERKALAEMIA 191 0.0054
378 PROCTALGIA 35 0.0054
379 FOETAL GROWTH RESTRICTION 33 0.0054
380 RIGHT VENTRICULAR FAILURE 38 0.0054
381 FEBRILE BONE MARROW APLASIA 23 0.0054
382 ODYNOPHAGIA 32 0.0054
383 COLITIS ISCHAEMIC 36 0.0053
384 LUNG INFILTRATION 47 0.0053
385 HEPATIC NECROSIS 20 0.0053
386 CARBOHYDRATE ANTIGEN 125 INCREASED 18 0.0053
387 HYPOALBUMINAEMIA 41 0.0053
388 POISONING 66 0.0052
389 PULMONARY OEDEMA 233 0.0052
390 HYPERPYREXIA 22 0.0052
391 LARYNGEAL OEDEMA 32 0.0052
392 ESCHERICHIA URINARY TRACT INFECTION 22 0.0052
393 ERYSIPELAS 26 0.0052
394 APLASTIC ANAEMIA 27 0.0052
395 INCORRECT DRUG ADMINISTRATION RATE 22 0.0052
396 ABSCESS LIMB 22 0.0052
397 FEELING OF DESPAIR 24 0.0051
398 HEPATITIS CHOLESTATIC 31 0.0051
399 DRUG TOLERANCE 26 0.0051
400 AMMONIA INCREASED 26 0.0051
401 ATRIOVENTRICULAR BLOCK COMPLETE 34 0.0051
402 PROCEDURAL PAIN 139 0.0050
403 HYPOVOLAEMIC SHOCK 24 0.0050
404 EYE MOVEMENT DISORDER 34 0.0050
405 ANAL INCONTINENCE 44 0.0049
406 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 35 0.0049
407 FEAR 131 0.0049
408 BREATH SOUNDS ABNORMAL 24 0.0049
409 DEFAECATION URGENCY 34 0.0048
410 VARICOSE VEIN 25 0.0048
411 PERIORBITAL OEDEMA 25 0.0048
412 MELANOCYTIC NAEVUS 21 0.0048
413 PULMONARY CONGESTION 63 0.0048
414 CORONARY ARTERY STENOSIS 24 0.0048
415 NEUTROPENIC SEPSIS 34 0.0048
416 POISONING DELIBERATE 45 0.0047
417 BUNDLE BRANCH BLOCK LEFT 20 0.0047
418 BLOOD CALCIUM DECREASED 53 0.0047
419 OBSTRUCTIVE AIRWAYS DISORDER 52 0.0047
420 HEPARIN-INDUCED THROMBOCYTOPENIA 23 0.0047
421 MENTAL STATUS CHANGES 129 0.0046
422 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 36 0.0046
423 INTESTINAL PERFORATION 52 0.0046
424 FAECES HARD 18 0.0046
425 HYPOMAGNESAEMIA 64 0.0046
426 HAEMATOCHEZIA 253 0.0046
427 THERAPY NON-RESPONDER 206 0.0046
428 CARDIAC DYSFUNCTION 17 0.0046
429 TOXIC SKIN ERUPTION 46 0.0046
430 DRUG USE DISORDER 38 0.0045
431 APHTHOUS ULCER 35 0.0045
432 NECROSIS 25 0.0045
433 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 319 0.0045
434 ALANINE AMINOTRANSFERASE INCREASED 275 0.0045
435 HAEMOLYTIC ANAEMIA 40 0.0045
436 FACIAL PARALYSIS 38 0.0045
437 BLOOD PROLACTIN INCREASED 21 0.0044
438 REFUSAL OF TREATMENT BY PATIENT 29 0.0044
439 CLOSTRIDIUM DIFFICILE COLITIS 47 0.0044
440 CYTOKINE RELEASE SYNDROME 88 0.0044
441 DYSKINESIA 178 0.0044
442 MOUTH HAEMORRHAGE 32 0.0044
443 THROMBOCYTOPENIA 485 0.0043
444 HYPOCALCAEMIA 82 0.0043
445 PARALYSIS 62 0.0043
446 ABSCESS 69 0.0043
447 TRANSAMINASES INCREASED 96 0.0043
448 RENAL INJURY 128 0.0043
449 BLOOD ALBUMIN DECREASED 34 0.0043
450 PNEUMOCYSTIS JIROVECII PNEUMONIA 43 0.0043
451 RENAL TUBULAR NECROSIS 42 0.0043
452 CEREBRAL ISCHAEMIA 22 0.0043
453 HAEMATEMESIS 108 0.0043
454 DUODENAL ULCER 30 0.0042
455 EJECTION FRACTION DECREASED 66 0.0042
456 PULMONARY HYPERTENSION 88 0.0042
457 ARRHYTHMIA 199 0.0042
458 EXTRASYSTOLES 29 0.0041
459 PATHOLOGICAL FRACTURE 21 0.0041
460 POST PROCEDURAL HAEMORRHAGE 48 0.0041
461 ANAL FISSURE 22 0.0041
462 STEVENS-JOHNSON SYNDROME 90 0.0040
463 DRUG-INDUCED LIVER INJURY 127 0.0040
464 INFLAMMATORY MARKER INCREASED 20 0.0040
465 PNEUMONIA BACTERIAL 37 0.0040
466 GRAND MAL CONVULSION 37 0.0040
467 RENAL IMPAIRMENT 332 0.0039
468 AGGRESSION 197 0.0039
469 RESTLESSNESS 143 0.0039
470 RENAL CYST 31 0.0039
471 URINARY RETENTION 130 0.0039
472 REBOUND EFFECT 44 0.0039
473 RENAL CELL CARCINOMA 19 0.0039
474 UMBILICAL HERNIA 18 0.0038
475 HAEMORRHOIDS 75 0.0038
476 MUCOUS STOOLS 19 0.0038
477 DRUG LEVEL DECREASED 39 0.0038
478 PRODUCT PREPARATION ISSUE 25 0.0038
479 NEUTROPHIL COUNT INCREASED 39 0.0038
480 INTENTIONAL OVERDOSE 244 0.0038
481 RENAL FAILURE 505 0.0038
482 COGNITIVE DISORDER 177 0.0038
483 RESPIRATION ABNORMAL 26 0.0038
484 BLOOD UREA INCREASED 63 0.0038
485 GRAFT VERSUS HOST DISEASE 27 0.0038
486 CARDIAC FAILURE ACUTE 25 0.0037
487 SUBARACHNOID HAEMORRHAGE 38 0.0037
488 SEPSIS 415 0.0037
489 HEPATITIS 95 0.0037
490 DRUG ABUSE 306 0.0037
491 GAMMA-GLUTAMYLTRANSFERASE INCREASED 81 0.0037
492 POST PROCEDURAL COMPLICATION 70 0.0036
493 VENOOCCLUSIVE LIVER DISEASE 18 0.0036
494 HYPERVOLAEMIA 18 0.0036
495 NERVOUS SYSTEM DISORDER 113 0.0036
496 ANHEDONIA 95 0.0036
497 SENSORY LOSS 29 0.0036
498 SALIVARY HYPERSECRETION 36 0.0036
499 BLOOD PRESSURE DECREASED 239 0.0036
500 SUDDEN DEATH 38 0.0036
501 CARDIAC TAMPONADE 17 0.0036
502 APHASIA 108 0.0036
503 EMPHYSEMA 36 0.0036
504 CHOLECYSTITIS ACUTE 20 0.0035
505 NORMAL NEWBORN 19 0.0035
506 EMBOLISM 29 0.0035
507 PSYCHOTIC DISORDER 103 0.0035
508 BLOOD BILIRUBIN INCREASED 94 0.0035
509 RESPIRATORY DISORDER 104 0.0035
510 MATERNAL EXPOSURE DURING PREGNANCY 309 0.0035
511 END STAGE RENAL DISEASE 63 0.0035
512 RALES 20 0.0034
513 ON AND OFF PHENOMENON 19 0.0034
514 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 35 0.0034
515 HYPERCALCAEMIA 42 0.0034
516 TRICUSPID VALVE INCOMPETENCE 27 0.0034
517 FOETAL EXPOSURE DURING PREGNANCY 276 0.0034
518 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 30 0.0034
519 UPPER GASTROINTESTINAL HAEMORRHAGE 57 0.0034
520 ASPARTATE AMINOTRANSFERASE INCREASED 178 0.0033
521 GENERALISED ERYTHEMA 19 0.0033
522 GASTROINTESTINAL INFLAMMATION 26 0.0033
523 HYDROCEPHALUS 18 0.0033
524 HYPONATRAEMIA 186 0.0033
525 SCREAMING 21 0.0033
526 HEPATIC FUNCTION ABNORMAL 123 0.0033
527 ANAEMIA 621 0.0033
528 TRANSPLANT REJECTION 26 0.0032
529 MOTOR DYSFUNCTION 33 0.0032
530 BRONCHOPULMONARY ASPERGILLOSIS 25 0.0032
531 RENAL FAILURE ACUTE 136 0.0032
532 METASTASES TO LUNG 37 0.0032
533 PALLOR 87 0.0032
534 PARKINSONISM 31 0.0032
535 METASTASES TO CENTRAL NERVOUS SYSTEM 41 0.0032
536 EXPOSURE DURING PREGNANCY 196 0.0032
537 TERMINAL STATE 21 0.0031
538 INGUINAL HERNIA 19 0.0031
539 HEART RATE DECREASED 109 0.0031
540 HAEMODIALYSIS 26 0.0031
541 MITRAL VALVE INCOMPETENCE 35 0.0031
542 FEBRILE NEUTROPENIA 205 0.0031
543 COORDINATION ABNORMAL 43 0.0031
544 CONCOMITANT DISEASE AGGRAVATED 19 0.0031
545 DECUBITUS ULCER 25 0.0031
546 DISORIENTATION 121 0.0031
547 IRON DEFICIENCY ANAEMIA 28 0.0030
548 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 52 0.0030
549 HALLUCINATION, VISUAL 64 0.0030
550 INCONTINENCE 32 0.0030
551 PLEURAL EFFUSION 184 0.0030
552 PYELONEPHRITIS 26 0.0030
553 OFF LABEL USE 2614 0.0030
554 HYPOPHOSPHATAEMIA 22 0.0030
555 PNEUMONITIS 81 0.0030
556 EXTRAPYRAMIDAL DISORDER 73 0.0029
557 BRADYPHRENIA 19 0.0029
558 APPENDICITIS 27 0.0029
559 NOCTURIA 35 0.0029
560 TUBULOINTERSTITIAL NEPHRITIS 54 0.0029
561 GASTROENTERITIS 42 0.0029
562 HYPERTENSIVE CRISIS 32 0.0029
563 JAUNDICE 77 0.0029
564 BLOOD ALKALINE PHOSPHATASE INCREASED 71 0.0029
565 DEVICE RELATED INFECTION 44 0.0029
566 SUICIDE ATTEMPT 172 0.0028
567 HEMIPARESIS 48 0.0028
568 PYREXIA 978 0.0028
569 ACUTE MYOCARDIAL INFARCTION 83 0.0028
570 SOMNOLENCE 565 0.0028
571 HYDRONEPHROSIS 21 0.0028
572 HEPATIC ENCEPHALOPATHY 26 0.0028
573 MYOPATHY 24 0.0028
574 ARTERIOSCLEROSIS 26 0.0028
575 HYPOKINESIA 40 0.0028
576 CARDIAC FAILURE 221 0.0028
577 LARGE INTESTINE PERFORATION 19 0.0027
578 EUPHORIC MOOD 28 0.0027
579 SPINAL OSTEOARTHRITIS 24 0.0027
580 LIVER INJURY 67 0.0027
581 LOSS OF CONSCIOUSNESS 349 0.0027
582 ESCHERICHIA INFECTION 22 0.0027
583 POLYNEUROPATHY 32 0.0027
584 EYELID OEDEMA 31 0.0027
585 BLOOD CREATININE INCREASED 174 0.0027
586 PRODUCT USE IN UNAPPROVED INDICATION 659 0.0027
587 INFUSION RELATED REACTION 176 0.0027
588 WITHDRAWAL SYNDROME 111 0.0026
589 DRUG INEFFECTIVE 3477 0.0026
590 CEREBRAL HAEMORRHAGE 94 0.0026
591 LIPASE INCREASED 20 0.0026
592 DISSOCIATION 20 0.0026
593 HALLUCINATION 196 0.0026
594 ANGIOEDEMA 115 0.0026
595 BODY TEMPERATURE INCREASED 53 0.0026
596 MALNUTRITION 29 0.0026
597 ULCER 41 0.0026
598 CAESAREAN SECTION 30 0.0026
599 HYPOTHYROIDISM 82 0.0026
600 DRUG WITHDRAWAL SYNDROME NEONATAL 38 0.0026
601 ARTERIOSCLEROSIS CORONARY ARTERY 17 0.0026
602 ABORTION INDUCED 24 0.0025
603 OVERDOSE 546 0.0025
604 SUBDURAL HAEMATOMA 36 0.0025
605 TUMOUR LYSIS SYNDROME 22 0.0025
606 MUSCLE TWITCHING 57 0.0025
607 RASH PUSTULAR 18 0.0025
608 ERYTHEMA MULTIFORME 23 0.0025
609 SUBSTANCE ABUSE 20 0.0025
610 HAEMATURIA 84 0.0025
611 GENERALISED OEDEMA 30 0.0024
612 CONFUSIONAL STATE 391 0.0024
613 HAEMORRHAGE INTRACRANIAL 36 0.0024
614 CONDITION AGGRAVATED 728 0.0024
615 CHRONIC KIDNEY DISEASE 181 0.0024
616 ASCITES 70 0.0024
617 NO THERAPEUTIC RESPONSE 29 0.0024
618 NEPHROPATHY 22 0.0024
619 ATRIAL FIBRILLATION 229 0.0023
620 HYPOPHAGIA 60 0.0023
621 DYSARTHRIA 88 0.0023
622 MOVEMENT DISORDER 75 0.0023
623 ABNORMAL FAECES 19 0.0023
624 GENERAL PHYSICAL HEALTH DETERIORATION 268 0.0023
625 LIVER FUNCTION TEST INCREASED 49 0.0023
626 EOSINOPHIL COUNT INCREASED 19 0.0023
627 HYPERGLYCAEMIA 83 0.0023
628 PANCREATITIS ACUTE 51 0.0023
629 IMMUNOSUPPRESSION 20 0.0023
630 INJURY 159 0.0023
631 DRUG ERUPTION 40 0.0023
632 SPEECH DISORDER 118 0.0022
633 ABDOMINAL PAIN 523 0.0022
634 HEPATOTOXICITY 50 0.0022
635 WHITE BLOOD CELL COUNT INCREASED 86 0.0022
636 URINARY INCONTINENCE 66 0.0022
637 PANCYTOPENIA 124 0.0022
638 TREATMENT FAILURE 183 0.0022
639 DEEP VEIN THROMBOSIS 143 0.0022
640 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
641 FACE OEDEMA 37 0.0022
642 HICCUPS 18 0.0022
643 ACUTE MYELOID LEUKAEMIA 34 0.0022
644 MELAENA 48 0.0022
645 OSTEOPENIA 33 0.0022
646 C-REACTIVE PROTEIN INCREASED 79 0.0022
647 INFLAMMATION 111 0.0021
648 ERYTHEMA 442 0.0021
649 NEPHROPATHY TOXIC 24 0.0021
650 THERAPY PARTIAL RESPONDER 33 0.0021
651 SMALL INTESTINAL OBSTRUCTION 26 0.0021
652 SPUTUM DISCOLOURED 20 0.0021
653 CARDIOMYOPATHY 31 0.0021
654 ABNORMAL BEHAVIOUR 83 0.0021
655 CONSTIPATION 454 0.0021
656 CORONARY ARTERY DISEASE 63 0.0021
657 MUCOSAL INFLAMMATION 54 0.0021
658 HYPOAESTHESIA ORAL 31 0.0021
659 ACCIDENTAL OVERDOSE 75 0.0020
660 WRONG DRUG ADMINISTERED 18 0.0020
661 HYPERTENSION 426 0.0020
662 HAEMATOMA 52 0.0020
663 HYPOGLYCAEMIA 97 0.0020
664 COMPLETED SUICIDE 166 0.0020
665 AGRANULOCYTOSIS 37 0.0020
666 AKATHISIA 27 0.0020
667 INTERNATIONAL NORMALISED RATIO INCREASED 56 0.0020
668 LIVER FUNCTION TEST ABNORMAL 57 0.0020
669 PROTEINURIA 37 0.0019
670 INTERVERTEBRAL DISC DEGENERATION 18 0.0019
671 HAEMOPTYSIS 54 0.0019
672 PULMONARY ARTERIAL HYPERTENSION 28 0.0019
673 SKIN LACERATION 21 0.0019
674 DEFORMITY 18 0.0019
675 CEREBRAL INFARCTION 47 0.0019
676 ABDOMINAL DISTENSION 200 0.0019
677 STAPHYLOCOCCAL INFECTION 63 0.0019
678 MENTAL IMPAIRMENT 46 0.0019
679 LYMPHADENOPATHY 67 0.0019
680 PNEUMONIA 611 0.0019
681 DYSURIA 69 0.0019
682 BONE MARROW FAILURE 38 0.0019
683 LUNG INFECTION 29 0.0019
684 PRESCRIBED OVERDOSE 36 0.0019
685 FLUID OVERLOAD 27 0.0019
686 HEPATOMEGALY 18 0.0018
687 MANIA 30 0.0018
688 GASTROINTESTINAL HAEMORRHAGE 152 0.0018
689 INTENTIONAL PRODUCT MISUSE 158 0.0018
690 DISTURBANCE IN ATTENTION 97 0.0018
691 LEUKOPENIA 89 0.0018
692 PULMONARY FIBROSIS 34 0.0018
693 INTENTIONAL PRODUCT USE ISSUE 155 0.0018
694 DIVERTICULITIS 49 0.0018
695 PLATELET COUNT INCREASED 23 0.0018
696 PANCREATITIS 93 0.0018
697 MOOD SWINGS 56 0.0018
698 PRODUCT AVAILABILITY ISSUE 40 0.0018
699 UPPER RESPIRATORY TRACT INFECTION 81 0.0018
700 DERMATITIS ALLERGIC 22 0.0017
701 BLOOD PRESSURE SYSTOLIC INCREASED 34 0.0017
702 PERITONITIS 36 0.0017
703 DELUSION 27 0.0017
704 BASAL CELL CARCINOMA 27 0.0017
705 PERICARDIAL EFFUSION 40 0.0017
706 RESPIRATORY TRACT INFECTION 45 0.0017
707 HEART RATE INCREASED 171 0.0017
708 PETECHIAE 18 0.0017
709 PULMONARY EMBOLISM 163 0.0017
710 LIP SWELLING 57 0.0017
711 GASTRITIS 45 0.0017
712 AMNESIA 111 0.0017
713 METASTASES TO BONE 28 0.0017
714 HEPATIC ENZYME INCREASED 116 0.0017
715 SWOLLEN TONGUE 53 0.0017
716 CLOSTRIDIUM DIFFICILE INFECTION 37 0.0017
717 IMPAIRED GASTRIC EMPTYING 23 0.0017
718 CYTOMEGALOVIRUS INFECTION 28 0.0017
719 BREAST CANCER METASTATIC 18 0.0017
720 HYPERLIPIDAEMIA 20 0.0017
721 INTERSTITIAL LUNG DISEASE 81 0.0017
722 LETHARGY 95 0.0016
723 ECONOMIC PROBLEM 25 0.0016
724 ADRENAL INSUFFICIENCY 20 0.0016
725 SCHIZOPHRENIA 20 0.0016
726 CONVULSION 94 0.0016
727 ANXIETY 467 0.0016
728 LYMPHOCYTE COUNT DECREASED 29 0.0016
729 TINNITUS 75 0.0016
730 DYSPEPSIA 160 0.0016
731 RASH GENERALISED 42 0.0016
732 TENDON RUPTURE 20 0.0016
733 DRUG WITHDRAWAL SYNDROME 142 0.0016
734 SECRETION DISCHARGE 20 0.0016
735 CHOLECYSTITIS 19 0.0016
736 METASTASES TO LIVER 28 0.0016
737 HYPERTHYROIDISM 23 0.0016
738 MYOCARDITIS 18 0.0016
739 MEDICATION ERROR 87 0.0016
740 HAEMATOCRIT DECREASED 31 0.0016
741 THINKING ABNORMAL 29 0.0016
742 MUSCLE SPASTICITY 19 0.0015
743 HAEMORRHAGE 160 0.0015
744 NEUTROPENIA 205 0.0015
745 BACTERIAL INFECTION 28 0.0015
746 SENSORY DISTURBANCE 24 0.0015
747 PULMONARY MASS 22 0.0015
748 PRODUCT USE ISSUE 277 0.0015
749 DISEASE PROGRESSION 174 0.0015
750 SLEEP APNOEA SYNDROME 28 0.0015
751 RASH ERYTHEMATOUS 70 0.0015
752 EMOTIONAL DISORDER 45 0.0015
753 OEDEMA 79 0.0015
754 EATING DISORDER 31 0.0015
755 IRRITABILITY 87 0.0014
756 HYPERHIDROSIS 185 0.0014
757 TREMOR 237 0.0014
758 UNEVALUABLE EVENT 108 0.0014
759 OSTEOARTHRITIS 60 0.0014
760 WEIGHT DECREASED 392 0.0014
761 PANIC ATTACK 51 0.0014
762 HEPATIC STEATOSIS 26 0.0014
763 FEEDING DISORDER 28 0.0014
764 DYSPHAGIA 131 0.0014
765 MALIGNANT NEOPLASM PROGRESSION 141 0.0014
766 CHROMATURIA 31 0.0014
767 GASTRIC ULCER 26 0.0014
768 PRODUCTIVE COUGH 65 0.0014
769 CONTRAINDICATED PRODUCT ADMINISTERED 41 0.0014
770 CONJUNCTIVITIS 25 0.0013
771 NO ADVERSE EVENT 244 0.0013
772 DRUG INTOLERANCE 130 0.0013
773 PLATELET COUNT DECREASED 142 0.0013
774 DEMENTIA 37 0.0013
775 VOMITING 622 0.0013
776 ORTHOSTATIC HYPOTENSION 23 0.0013
777 LOWER RESPIRATORY TRACT INFECTION 60 0.0013
778 NEURALGIA 32 0.0013
779 DISABILITY 26 0.0013
780 MYELODYSPLASTIC SYNDROME 19 0.0013
781 DISEASE RECURRENCE 62 0.0013
782 URINARY TRACT INFECTION 222 0.0013
783 DECREASED APPETITE 301 0.0013
784 LIVER DISORDER 57 0.0013
785 OEDEMA PERIPHERAL 155 0.0013
786 DIALYSIS 18 0.0013
787 URTICARIA 212 0.0013
788 EMOTIONAL DISTRESS 152 0.0013
789 WHEEZING 74 0.0012
790 TREATMENT NONCOMPLIANCE 68 0.0012
791 CORONARY ARTERY OCCLUSION 17 0.0012
792 HEAD INJURY 39 0.0012
793 HAEMOGLOBIN DECREASED 126 0.0012
794 HEPATIC CIRRHOSIS 23 0.0012
795 CHILLS 143 0.0012
796 BLOOD PRESSURE ABNORMAL 24 0.0012
797 INCORRECT ROUTE OF DRUG ADMINISTRATION 43 0.0012
798 NEUTROPHIL COUNT DECREASED 49 0.0012
799 DEPRESSED MOOD 63 0.0012
800 SUICIDAL IDEATION 109 0.0012
801 CANDIDA INFECTION 20 0.0012
802 DYSPNOEA 665 0.0012
803 MUSCLE TIGHTNESS 19 0.0012
804 CELLULITIS 59 0.0012
805 FUNGAL INFECTION 39 0.0012
806 DYSPNOEA EXERTIONAL 44 0.0012
807 NEUROPATHY PERIPHERAL 111 0.0012
808 LUNG DISORDER 57 0.0012
809 EPISTAXIS 87 0.0012
810 OSTEOMYELITIS 21 0.0012
811 MEMORY IMPAIRMENT 159 0.0012
812 NEPHROLITHIASIS 53 0.0012
813 DIPLOPIA 30 0.0012
814 FAECES DISCOLOURED 25 0.0012
815 MOUTH ULCERATION 24 0.0011
816 PRODUCT ADMINISTRATION ERROR 23 0.0011
817 DRUG EFFECT INCOMPLETE 41 0.0011
818 INFECTION 163 0.0011
819 RETCHING 24 0.0011
820 HYPERSOMNIA 32 0.0011
821 MENTAL DISORDER 48 0.0011
822 PRODUCT PRESCRIBING ISSUE 24 0.0011
823 THERAPEUTIC PRODUCT EFFECT DECREASED 49 0.0011
824 INSOMNIA 291 0.0011
825 SYNCOPE 109 0.0011
826 CHOLELITHIASIS 35 0.0011
827 ISCHAEMIC STROKE 19 0.0011
828 MUSCULOSKELETAL STIFFNESS 92 0.0010
829 SWELLING FACE 68 0.0010
830 ABDOMINAL PAIN LOWER 26 0.0010
831 CARDIOVASCULAR DISORDER 26 0.0010
832 BALANCE DISORDER 88 0.0010
833 PAIN 625 0.0010
834 THIRST 18 0.0010
835 MUSCULAR WEAKNESS 114 0.0010
836 RASH MACULAR 35 0.0010
837 DEPRESSION 227 0.0010
838 BLOOD PRESSURE INCREASED 152 0.0010
839 GAIT INABILITY 33 0.0010
840 HYPERSENSITIVITY 183 0.0010
841 STOMATITIS 59 0.0010
842 RASH 424 0.0010
843 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
844 DRUG DEPENDENCE 154 0.0010
845 DIABETIC KETOACIDOSIS 23 0.0010
846 DEHYDRATION 126 0.0009
847 GASTROINTESTINAL DISORDER 84 0.0009
848 FLATULENCE 53 0.0009
849 MALAISE 406 0.0009
850 CHEST PAIN 171 0.0009
851 ORAL HERPES 18 0.0009
852 BLOOD GLUCOSE ABNORMAL 17 0.0009
853 GAIT DISTURBANCE 176 0.0009
854 BLOOD PRESSURE FLUCTUATION 22 0.0009
855 NAUSEA 711 0.0009
856 BLOOD POTASSIUM DECREASED 27 0.0009
857 OROPHARYNGEAL PAIN 82 0.0009
858 RIB FRACTURE 18 0.0009
859 ANGINA PECTORIS 25 0.0009
860 DYSPHONIA 51 0.0009
861 BONE DENSITY DECREASED 27 0.0009
862 DEATH 742 0.0009
863 COVID-19 150 0.0009
864 DRUG EFFECT DECREASED 46 0.0009
865 DIARRHOEA 551 0.0009
866 DISCOMFORT 52 0.0009
867 MOBILITY DECREASED 61 0.0008
868 OSTEONECROSIS OF JAW 21 0.0008
869 ASTHENIA 316 0.0008
870 IRRITABLE BOWEL SYNDROME 18 0.0008
871 TRANSIENT ISCHAEMIC ATTACK 28 0.0008
872 ANGER 28 0.0008
873 SKIN DISCOLOURATION 38 0.0008
874 CRYING 30 0.0008
875 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 43 0.0008
876 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 24 0.0008
877 SKIN ULCER 21 0.0008
878 COUGH 227 0.0008
879 THERAPEUTIC RESPONSE DECREASED 48 0.0008
880 FALL 263 0.0008
881 FLUSHING 80 0.0008
882 PAIN IN JAW 22 0.0008
883 RED BLOOD CELL COUNT DECREASED 22 0.0008
884 RASH PRURITIC 41 0.0008
885 WHITE BLOOD CELL COUNT DECREASED 82 0.0008
886 PRODUCT PRESCRIBING ERROR 18 0.0008
887 HEADACHE 473 0.0008
888 FEELING HOT 46 0.0007
889 DRUG ADMINISTRATION ERROR 23 0.0007
890 INTESTINAL OBSTRUCTION 28 0.0007
891 PRESYNCOPE 18 0.0007
892 IMPAIRED HEALING 24 0.0007
893 OSTEOPOROSIS 30 0.0007
894 SKIN LESION 20 0.0007
895 THERAPY INTERRUPTED 52 0.0007
896 WOUND 20 0.0007
897 PRODUCT COMPLAINT 18 0.0007
898 HYPOAESTHESIA 106 0.0007
899 GASTROOESOPHAGEAL REFLUX DISEASE 57 0.0007
900 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 34 0.0007
901 CATARACT 42 0.0007
902 CHEST DISCOMFORT 72 0.0007
903 ROAD TRAFFIC ACCIDENT 29 0.0007
904 CARDIAC FAILURE CONGESTIVE 55 0.0007
905 RHINORRHOEA 44 0.0007
906 FEMUR FRACTURE 21 0.0007
907 BLISTER 38 0.0007
908 RENAL DISORDER 31 0.0007
909 NECK PAIN 37 0.0007
910 VISUAL IMPAIRMENT 81 0.0007
911 CONTUSION 62 0.0006
912 MUSCLE SPASMS 118 0.0006
913 DIZZINESS 318 0.0006
914 BACK PAIN 146 0.0006
915 PRODUCT QUALITY ISSUE 85 0.0006
916 POLLAKIURIA 26 0.0006
917 ARTHRALGIA 257 0.0006
918 CEREBROVASCULAR ACCIDENT 104 0.0006
919 LABORATORY TEST ABNORMAL 18 0.0006
920 VISUAL ACUITY REDUCED 20 0.0006
921 SKIN DISORDER 20 0.0006
922 LACRIMATION INCREASED 18 0.0006
923 HIP FRACTURE 19 0.0006
924 NIGHT SWEATS 19 0.0006
925 INFLUENZA 65 0.0006
926 NASAL CONGESTION 34 0.0006
927 PARAESTHESIA 91 0.0006
928 DIABETES MELLITUS 44 0.0006
929 VIRAL INFECTION 19 0.0006
930 DRUG EXPOSURE DURING PREGNANCY 19 0.0006
931 PRODUCT SUBSTITUTION ISSUE 32 0.0006
932 DRY MOUTH 45 0.0006
933 ECZEMA 29 0.0006
934 WRONG TECHNIQUE IN DRUG USAGE PROCESS 20 0.0005
935 WEIGHT INCREASED 122 0.0005
936 ILLNESS 56 0.0005
937 EXTRA DOSE ADMINISTERED 22 0.0005
938 SLEEP DISORDER 38 0.0005
939 ABDOMINAL PAIN UPPER 110 0.0005
940 SWELLING 50 0.0005
941 MYOCARDIAL INFARCTION 93 0.0005
942 MYALGIA 89 0.0005
943 NEOPLASM PROGRESSION 18 0.0005
944 PALPITATIONS 60 0.0005
945 FATIGUE 398 0.0005
946 PRURITUS 195 0.0005
947 HOSPITALISATION 77 0.0005
948 SINUSITIS 50 0.0005
949 DRY EYE 24 0.0005
950 VISION BLURRED 66 0.0005
951 EYE PAIN 27 0.0005
952 BRONCHITIS 35 0.0005
953 JOINT SWELLING 57 0.0005
954 HERPES ZOSTER 26 0.0005
955 BLINDNESS 18 0.0004
956 THROMBOSIS 35 0.0004
957 ASTHMA 49 0.0004
958 BONE PAIN 25 0.0004
959 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
960 ADVERSE DRUG REACTION 38 0.0004
961 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 76 0.0004
962 NERVOUSNESS 22 0.0004
963 BLOOD GLUCOSE INCREASED 79 0.0004
964 ADVERSE EVENT 38 0.0004
965 PAIN IN EXTREMITY 120 0.0004
966 MUSCULOSKELETAL PAIN 21 0.0004
967 FEELING ABNORMAL 96 0.0004
968 MIGRAINE 38 0.0004
969 CARDIAC DISORDER 37 0.0004
970 VERTIGO 24 0.0004
971 INCORRECT DOSE ADMINISTERED 88 0.0004
972 DYSGEUSIA 28 0.0004
973 SURGERY 22 0.0004
974 THERAPY CESSATION 18 0.0004
975 ILL-DEFINED DISORDER 21 0.0003
976 UNDERDOSE 25 0.0003
977 PRODUCT DOSE OMISSION ISSUE 100 0.0003
978 NASOPHARYNGITIS 60 0.0003
979 PERIPHERAL SWELLING 50 0.0003
980 SKIN EXFOLIATION 27 0.0003
981 ARTHRITIS 25 0.0003
982 ABDOMINAL DISCOMFORT 53 0.0003
983 INFLUENZA LIKE ILLNESS 26 0.0003
984 NEOPLASM MALIGNANT 21 0.0003
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 58 0.0003
986 ALOPECIA 50 0.0003
987 HOT FLUSH 19 0.0003
988 BURNING SENSATION 17 0.0002
989 DRY SKIN 32 0.0002
990 INJECTION SITE PAIN 68 0.0002
991 ACCIDENTAL EXPOSURE TO PRODUCT 22 0.0002
992 INJECTION SITE ERYTHEMA 22 0.0002